IMMUCELL CORP
ICCC·452525306·US·Common Stock·Healthcare - Biotechnology-Activist
ICCC (IMMUCELL CORP) is held by 20 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($2.7M), MORGAN STANLEY ($2.4M), RENAISSANCE TECHNOLOGIES LLC ($1.7M). Net institutional sentiment: Bullish.
20
Holders
$11.3M
Total Value
80% (15)
Consensus
12 buying - 3 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 27, 2026 · Insiders Jun 22, 2026 · Activists Nov 20, 2025 · Congress none
InsiderTOte Boekhorst Paul Francis OlivierBuy $76KJun 18, 2026
InsiderTSTomsche David ScottBuy $8KNov 25, 2025
InsiderTSTomsche David ScottBuy $8KNov 25, 2025
Checking access…
Top Holders
Checking access…
Showing 1-20 of 20
Continue exploring
Other Healthcare stocks held by institutions
403 holders · $856.6B
403 holders · $286.8B
388 holders · $148B
385 holders · $405.5B
384 holders · $95B
381 holders · $105.8B
378 holders · $226B
375 holders · $51.2B
373 holders · $296.3B
371 holders · $110.7B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer